BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2003
View Archived Issues
Company Profile: Adventrx Pharmaceuticals
Read More
Melatonin as a novel therapy for Alzheimer's disease
Read More
Beta-L-2'-Fd4C shows antiviral activity and favorable pharmacokinetics in HBV
Read More
Sulphamoylated estrogen derivatives show potential in treating drug-resistant breast cancer
Read More
Yamanouchi and GlaxoSmithKline to copromote Vesicare in U.S.
Read More
Enrollment opens in phase II trial of Tarceva in malignant glioma
Read More
Phase II trial preparations advance for Norwood Immunology technology
Read More
Incara selects AEOL-10150 as candidate for ALS
Read More
FDA approves Trileptal for children
Read More
Paratek claims non-antibacterial tetracyclines for cancer, stroke and lung injury
Read More
Novel antibacterial tetracyclines in Paratek development pipeline
Read More
Receptor tyrosine kinase inhibitors and their use reported by Theravance
Read More
Novel 5-HT2C receptor ligands and their use as antiobesity agents
Read More
Novel series of Syk kinase inhibitors covered by Boehringer Ingelheim patent
Read More
Phase II DCF-987 trial completes enrollment
Read More
Ceregene acquires rights to ALS gene therapy from Salk Institute
Read More
ViroPharma acquires maribavir rights from GlaxoSmithKline
Read More
FDA Advisory Committee schedules review of Metvix for basal cell carcinoma
Read More
SGN-35 selectively targets CD30-positive malignancies in models of Hodgkin's disease
Read More
Caprion and AstraZeneca collaborate on pain biomarker research
Read More